Ahern MJ - Search Results

1

Shared rheumatoid epitope as a risk factor in determining outcome in rheumatoid arthritis.

Hedger SC, Macardle P, Bond MJ, Ahern MJ, Smith MD, Roberts-Thomson PJ. Hedger SC, et al. Among authors: ahern mj. Aust N Z J Med. 1999 Apr;29(2):234-8. doi: 10.1111/j.1445-5994.1999.tb00689.x. Aust N Z J Med. 1999. PMID: 10342023

2

The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. II. Effects on immune and inflammatory indices in peripheral blood.

Smith MD, Ahern MJ, Brooks PM, Roberts-Thomson PJ. Smith MD, et al. Among authors: ahern mj. J Rheumatol. 1988 Feb;15(2):233-7. J Rheumatol. 1988. PMID: 3361535

3

The longterm effect of pulsed corticosteroids on the efficacy and toxicity of chrysotherapy in rheumatoid arthritis.

Heytman M, Ahern MJ, Smith MD, Roberts-Thomson PJ. Heytman M, et al. Among authors: ahern mj. J Rheumatol. 1994 Mar;21(3):435-41. J Rheumatol. 1994. PMID: 8006886 Clinical Trial.

4

Response of soluble IL-2 receptor levels during gold therapy for rheumatoid arthritis.

Sheldon A, Ahern MJ, Smith MD, Zola H, Roberts-Thomson PJ. Sheldon A, et al. Among authors: ahern mj. Clin Exp Rheumatol. 1994 Mar-Apr;12(2):175-8. Clin Exp Rheumatol. 1994. PMID: 8039284

5

A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy.

Chandran G, Smith M, Ahern MJ, Roberts-Thomson PJ. Chandran G, et al. Among authors: ahern mj. Aust N Z J Med. 1995 Dec;25(6):688-94. doi: 10.1111/j.1445-5994.1995.tb02854.x. Aust N Z J Med. 1995. PMID: 8770332

6

Rheumatoid arthritis.

Ahern MJ, Smith MD. Ahern MJ, et al. Med J Aust. 1997 Feb 3;166(3):156-61. Med J Aust. 1997. PMID: 9059442 Review. No abstract available.

7

Clinical utility of the flow cytometric technique for shared rheumatoid epitope.

Hedger S, Geddes RA, Wheatland L, Macardle P, Smith MD, Ahern MJ, Roberts-Thomson PJ. Hedger S, et al. Among authors: ahern mj. Rheumatol Int. 1999;19(1-2):31-4. doi: 10.1007/s002960050096. Rheumatol Int. 1999. PMID: 10651079

8

Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome.

Haynes D, Crotti T, Weedon H, Slavotinek J, Au V, Coleman M, Roberts-Thomson PJ, Ahern M, Smith MD. Haynes D, et al. Arthritis Rheum. 2008 Jul 15;59(7):911-20. doi: 10.1002/art.23818. Arthritis Rheum. 2008. PMID: 18576301 Free article.

9

Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment.

Smith MD, Weedon H, Papangelis V, Walker J, Roberts-Thomson PJ, Ahern MJ. Smith MD, et al. Among authors: ahern mj. Rheumatology (Oxford). 2010 May;49(5):862-75. doi: 10.1093/rheumatology/kep467. Epub 2010 Feb 10. Rheumatology (Oxford). 2010. PMID: 20147446

10

Pulse methylprednisolone in rheumatoid arthritis: effects on peripheral blood and synovial fluid neutrophil surface phenotype.

Youssef P, Roberts-Thomson P, Ahern M, Smith M. Youssef P, et al. J Rheumatol. 1995 Nov;22(11):2065-71. J Rheumatol. 1995. PMID: 8596146 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters